Executive Team

Keeley Aleman was appointed Senior Vice President, General Counsel and Secretary for Waters Corporation in 2019. She is responsible for all legal matters globally and for Waters’ environmental, social, and governance program.

Keeley joined Waters Corporation in 2006 as the Assistant General Counsel. In her time at Waters, she has served in various roles of increasing responsibility, including as Vice President, Deputy General Counsel and Assistant Secretary, Associate General Counsel and Assistant General Counsel for Waters. She advises on business transactions, commercial strategies, mergers and acquisitions, intellectual property, compliance, corporate governance, and organizational matters.

Prior to joining Waters, Keeley was an attorney with Goodwin Procter LLP and Testa, Hurwitz & Thibeault, LLP.

Massachusetts’s Lawyer Weekly recognized Keeley in 2017’s Top Women of the Law.

She earned her B.A., with honors, from University of California at Davis and received her J.D., magna cum laude, from Boston University School of Law.

Jianqing Bennett was appointed Senior Vice President of the TA Instruments Division of Waters Corporation in 2021 and assumed leadership of the Clinical Business in 2022. She is responsible for leading the TA Instruments Division into high-growth markets with analytical solutions for materials and life sciences customers, as well as establishing the Waters Clinical Business as an industry leader in mass spectrometry diagnostics.

Prior to joining Waters, Jianqing was Senior Vice President, High Growth Markets at Beckman Coulter Diagnostics (a Danaher operating company), where she was responsible for the P&L of High Growth Markets and managed the full portfolio of in vitro clinical core laboratory solutions, helping to accelerate revenue growth and market share gain. Prior to Beckman Coulter Diagnostics, she served in roles of increasing responsibility over 14 years at Carestream Health, including President of the Medical Digital Business from 2015 to 2017.

Prior to Carestream Health, Jianqing served in multiple roles at GE Healthcare Inc. in the U.S. from 2001 to 2003 and China from 1995 to 1999.

She holds a B.S. in biomedical engineering from Fudan University in Shanghai, China and an MBA in management information systems from The University of Iowa.

Kristen Garvey was appointed Vice President of Corporate Communications of Waters Corporation in 2019 after joining the company in 2018. She is responsible for Waters’ communication strategy across multiple stakeholder groups and oversees public relations, corporate branding, community involvement, and executive and employee communications. Kristen leads the effort to drive affinity and awareness for the Waters brand globally.

Prior to joining Waters, Kristen led internal communications at EMC and Dell Technologies, playing a significant role in the communication strategy for the largest technology merger in IT history. A marketer at heart, Kristen has held a variety of marketing leadership positions at Chadwick Martin Bailey and DataViz.

Kristen serves on the Board of The New England Council and has been appointed to the Board of Trustees for Worcester State University. She earned a B.A. in communications from the University of Massachusetts Amherst.

Chris Ross was appointed Senior Vice President, Global Operations of Waters Corporation in 2022. He is responsible for Waters worldwide Manufacturing, Supply Chain & Distribution, Facilities, Health & Safety, Procurement and Quality.

Prior to joining Waters, Chris spent the last 14 years at MilliporeSigma, the $9 billion Life Science business of Merck KGaA, Darmstadt, Germany, where he was most recently the Interim Sector Head of Life Science and Head of Integrated Supply Chain Operations. As Interim Sector Head of Life Science, he was responsible for leading the strategic direction of the business collaborating with the global scientific community to solve the industry's toughest problems, making research and biotech production simpler, faster, and safer. As Head of Integrated Supply Chain Operations, he was responsible for global manufacturing, supply chain, and global distribution driving improvements in cost, quality, and delivery of products. He was appointed US Country Speaker for Merck KGaA, Darmstadt, Germany in 2019, driving a one-company approach and representing the company across the United States.

Chris serves on the board of The New England Council and Boston Chamber of Commerce. He earned an MBA from the University of Washington in Seattle and a B.S. in electrical engineering from Worcester Polytechnic Institute.

Dr. Daniel Rush was appointed Senior Vice President, Strategy and Transformation of Waters Corporation in 2021. In this role, he collaborates with the Executive Committee to develop and operationalize worldwide enterprise strategy, shares responsibility for M&A, and leads the Global Research function.

Prior to joining Waters, Dan served as Vice President, Worldwide Commercialization Strategy & Innovation at Bristol Myers Squibb (BMS), where he led its digital customer model transformation and was responsible for implementing a novel innovation system across Commercial, Medical and Market Access. Prior to BMS, he spent eight years at Novartis in a variety of sales, marketing, and strategy leadership roles, including Head of Global Pharma Strategy, U.S. Launch Lead for Afinitor® and U.S. Marketing Director for Zometa®.

Dan began his career as a chemist in Pharmaceutical R&D at Merck, following a post-doc in materials science at the University of California, Irvine and Sandia National Laboratories.

He earned a B.A. in chemistry and history from Bowdoin College and a Ph.D. in physical organic chemistry from Yale University.